Table 1.
Group | N | Male/Female | Median duration of dementia at time of LP (range) | Median age at LP (range) | Median duration from LP to death (range) | |
---|---|---|---|---|---|---|
FTD |
|
34 |
15/19 |
3 (1–9) |
70 (38–85) |
- |
|
bvFTD |
23 |
12/11 |
3 (1–9) |
72 (38–85) |
- |
|
SD |
7 |
2/5 |
2 (1–4) |
64 (53–78) |
- |
|
PNFA |
4 |
1/3 |
3 (1–5) |
69 (66–77) |
- |
AD |
|
20 |
7/13 |
2 (1–7) |
72 (49–84) |
- |
Healthy controls |
|
26 |
12/14 |
NA |
70 (56–83) |
- |
NP verified FTD |
|
10 |
5/5 |
3 (0.4-12) |
63 (32–78) |
2 (0.1-8) |
|
Tau-pos |
3 |
1/2 |
5 (4–7) |
69 (50–78) |
3 (2–4) |
Tau-neg | 7 | 4/3 | 3 (0.4-12) | 60 (32–67) | 2 (0.1-8) |